InvestorsHub Logo

DayDreeming

06/05/18 8:59 PM

#17829 RE: soak #17828

Don't kid yourself, the majority of bio-tech companies fail and most of them had investors who thought they were investing in a product worth investing in, just like Oncolix has.

reaper247

06/06/18 1:19 AM

#17837 RE: soak #17828

Lets shatter a trading myth and expand on your post.

Public companies are allowed to divulge insider information to investors who have substantial positions in the company, contrary to popular belief.

It is the responsibility of those investors to not trade or publically share insider information until made public.

For these investors to agree to those terms hints that ONCX FDA progress may be positive.

If ONCX releases positive news about the second dosing group, you have deep pockets able to then participate in open market purchases.

We could then see a few SC -13G filings, which would confirm what most of us suspect.

ONCX is real company, with a real chance, to bring a viable Cancer treatment to market.

No wonder the Susan G. Komen Foundation provided early grants for Prolanta development.

IMO and FWIW.